Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies

ABSTRACT

Curcumin has been shown to have a wide variety of therapeutic effects, ranging from anti-inflammatory, chemopreventive, anti-proliferative, and anti-metastatic. This review provides an overview of the recent research conducted to overcome the problems with the bioavailability of curcumin, and of the preclinical and clinical studies that have reported success in combinatorial strategies coupling curcumin with other treatments. Research on the signaling pathways that curcumin treatment targets shows that it potently acts on major intracellular components involved in key processes such as genomic modulations, cell invasion and cell death pathways. Curcumin is a promising molecule for the prevention and treatment of cancer.

KEYWORDS:

• Curcumin
• Chemotherapy
• Apoptosis
• Synergistic effect
• Bioavailability

Acknowledgments

The authors would like to thank Ms. Nina Merrywheather for the editing of the text.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.